HAEMONETICS CORP (HAE)

Surgical & Medical Instruments & Apparatus

Latest Price

$106.20

TTM P/E

51.30

Normalized P/E

45.86

Div Yield

Book Value

18.45

P/B Ratio

5.75

Valuation metrics

EPS: $2.05

Book value / share: $17.60

Formula: √(22.5 × EPS × BVPS)

Graham Number

$28.49

73% downside

Norm. op. income: $156M (median of 7yr)

Tax rate: 22%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$5.00

95% downside

Base FCF: $142M (median of recent 5yr)

Growth: 14%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$86.44

19% downside

EPS: $2.05

Target P/E: 46×

Formula: EPS × P/E

P/E Fair Value

$94.30

11% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	5.91M	$443.0M	13.00%	+289.3K	2026-06-30
NEUBERGER BERMAN GROUP LLC	4.18M	$313.0M	9.19%	+618.5K	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	2.55M	$190.0M	5.60%	-12.9K	2026-06-30
AQR CAPITAL MANAGEMENT LLC	2.27M	$165.0M	4.98%	-1.09M	2026-06-30
ARIEL INVESTMENTS, LLC	2.06M	$154.0M	4.53%	--	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	2.06M	$154.0M	4.53%	-30.8K	2026-06-30
STATE STREET CORP	1.82M	$136.0M	4.00%	+45.3K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	1.59M	$118.0M	3.49%	+259.2K	2026-06-30
CITADEL ADVISORS LLC	1.54M	$115.0M	3.39%	+1.26M	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	1.29M	$96.0M	2.83%	+68.3K	2026-06-30